{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:26:19Z","timestamp":1753356379999},"reference-count":21,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T00:00:00Z","timestamp":1324339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust NZ J Obst Gynaeco"],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:p>\n            <jats:bold>Aims:\u2002<\/jats:bold> We performed an age\u2010matched case\u2013control study to compare the clinical and pathology outcomes between histologically diagnosed primary malignant mixed m\u0171llerian tumour (MMMT) of the uterus and endometrial carcinoma.<\/jats:p><jats:p>\n            <jats:bold>Methods:\u2002<\/jats:bold> Thirty\u2010two women were treated for primary MMMT at seven tertiary medical centres in Korea from 2000 to 2006. For each woman with MMMT, four women with endometrioid and two with non\u2010endometrioid endometrial carcinoma were selected as age\u2010matched controls for analysis. Medical records were retrospectively reviewed to obtain outcome data.<\/jats:p><jats:p>\n            <jats:bold>Results:\u2002<\/jats:bold> The incidence of MMMT was 2.57% (32\/1244). In comparison with women with endometrioid endometrial cancer, those with MMMT were characterised by large tumour size, higher incidence of adnexal involvement and lymph node metastases, leading to advanced disease stage. Despite the frequent use of adjuvant treatment, the 5\u2010year survival rate of women with MMMT was significantly poorer than those with endometrioid endometrial cancer. However, women with MMMT were not significantly different from those with non\u2010endometrioid endometrial cancer in terms of important pathologic variables, apart from larger tumour size. In addition, the 5\u2010year survival rate of women MMMT was poorer than that those with non\u2010endometrioid endometrial cancer, but the difference was not statistically significant.<\/jats:p><jats:p>\n            <jats:bold>Conclusions:\u2002<\/jats:bold> Malignant mixed m\u0171llerian tumour is characterised by a high incidence of lymph node metastases and advanced stage at diagnosis, leading to poorer overall survival than other subtypes of endometrial carcinoma. Clinical trials for MMMT are critical for improving treatment strategies.<\/jats:p>","DOI":"10.1111\/j.1479-828x.2011.01389.x","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T13:05:26Z","timestamp":1324386326000},"page":"44-48","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The comparison of clinicopathological characteristics in primary malignant mixed m\u0171llerian tumour with epithelial endometrial carcinoma"],"prefix":"10.1111","volume":"52","author":[{"given":"Seo\u2010Yun","family":"TONG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong\u2010Min","family":"LEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young\u2010Joon","family":"CHOI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae\u2010Kwan","family":"LEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jao Weon","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi\u2010Heum","family":"CHO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok\u2010Mo","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang\u2010Yoon","family":"PARK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan\u2010Yong","family":"PARK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki\u2010Tae","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,12,20]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"399","article-title":"The epidemiology of sarcomas of the uterus","volume":"76","author":"Harlow BL","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2009.05.020"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.09.023"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-199001000-00001"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.4941"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.04.027"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2008.12.009"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2010.21.3.151"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2009.41.3.122"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2007.39.4.139"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.05.009"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2009.02467.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0535-0"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-199501000-00007"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318176157c"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e31819a1fa5"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.09.029"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.00.7617"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.8326"},{"key":"e_1_2_5_21_2","unstructured":"NCCN clinical practice guidelines in oncology: uterine neoplasms. Available from:http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/uterine.pdf."},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.04.001"}],"container-title":["Australian and New Zealand Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1479-828X.2011.01389.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1479-828X.2011.01389.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T12:49:08Z","timestamp":1697374148000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1479-828X.2011.01389.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,20]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1111\/j.1479-828X.2011.01389.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1479-828x.2011.01389.x","archive":["Portico"],"relation":{},"ISSN":["0004-8666","1479-828X"],"issn-type":[{"value":"0004-8666","type":"print"},{"value":"1479-828X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,20]]},"assertion":[{"value":"2011-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}